Evidence map›Paper›PMID 33996761›Full record

ArticleFrontiers in chemistry2021

Heterologous Expression and Biochemical Characterization of the Human Zinc Transporter 1 (ZnT1) and Its Soluble C-Terminal Domain.

Camila A Cotrim, Russell J Jarrott, Andrew E Whitten, Hassanul G Choudhury, David Drew, Jennifer L Martin

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. CFTR is required for zinc-mediated antibacterial defense in human macrophages.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  4. Over-Production of the Human SLC7A10 inInternational journal of molecular sciences · 2023
    Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Camila A CotrimGriffith Institute for Drug Discovery, Griffith University, Nathan, QLD, Australia.
Russell J JarrottGriffith Institute for Drug Discovery, Griffith University, Nathan, QLD, Australia.
Andrew E WhittenAustralian Nuclear Science and Technology Organisation, Lucas Heights, NSW, Australia.
Hassanul G ChoudhuryInstitute for Molecular Bioscience, University of Queensland, St Lucia, QLD, Australia.
David DrewDepartment of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden.
Jennifer L MartinGriffith Institute for Drug Discovery, Griffith University, Nathan, QLD, Australia.
Griffith University · AUAustralian Nuclear Science and Technology Organisation · AUStockholm University · SEUniversity of Queensland · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human zinc transporter 1 (hZnT1) belongs to the cation diffusion facilitator (CDF) family. It plays a major role in transporting zinc (Zn

Indexed as

cation diffusion facilitatorC-terminal domainhuman zinc transporter 1membrane proteinssmall-angle X-ray scattering

Identifiers

PMID33996761
PMCPMC8120272
OpenAlexW3158109839

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.